Keyphrases
Inhalation Injury
100%
Immune Dysfunction
100%
Innate Immune Response
100%
Modal
100%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
100%
Inhalation
42%
Associated Morbidity
28%
Therapeutic Approaches
28%
Mammalian Target of Rapamycin (mTOR)
28%
Homeostasis
28%
Damage-associated Molecular Patterns
28%
Clinical Model
28%
American Burn Association
14%
Pharmacological Activation
14%
Nrf2 Knockout
14%
Immune Homeostasis
14%
Trifecta
14%
Multimodal Therapeutics
14%
Immune Cell Recruitment
14%
Protein Translation
14%
Erythroid
14%
Uncontrolled Inflammation
14%
Inflammatory Cytokines
14%
Prediction Model
14%
Existing Knowledge
14%
Mouse Model
14%
Knowledge Gaps
14%
Increased Vulnerability
14%
Reactive Oxygen Species
14%
Patient Outcomes
14%
Susceptibility to Infection
14%
Microparticles
14%
Immune Regulator
14%
Wild Mice
14%
Human Cohort
14%
Infectious Agents
14%
Inflammatory Chemokines
14%
Am(III)
14%
Clinical Problems
14%
Nrf2 Activation
14%
Translocated
14%
Human Samples
14%
Burn Injury
14%
Sampling Model
14%
Burn Patients
14%
Bacterial Infection
14%
Specific Mechanisms
14%
Infection Risk
14%
Medicine and Dentistry
Lung Burn
100%
Immune Disorder
100%
Thermal Burn
66%
Homeostasis
33%
Mechanistic Target of Rapamycin
22%
Immunity
22%
Microparticle
11%
Translation (Protein Synthesis)
11%
Inflammatory Cytokine
11%
Bacterial Infection
11%
Immunocompetent Cell
11%
Transcription Factor Nrf2
11%
Infection
11%
Chemokine
11%
Reactive Oxygen Species
11%
Exhalation
11%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Burn
100%
Burn
66%
Mammalian Target of Rapamycin
22%
Immune Injury
11%
Cytokine
11%
Infectious Agent
11%
Reactive Oxygen Metabolite
11%
Inflammation
11%
Microparticle
11%
Chemokine
11%
Wild Type Mouse
11%
Infection
11%
Transcription Factor Nrf2
11%
Mouse Model
11%
Bacterial Infection
11%